M Pandiri

机构：Vesta Sciences (United States)

发表论文 13 篇 · 总被引 7 次 · h-index 1

代表论文

• Karyotypic clonal fraction predicts adverse outcome in TP53 -mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study (2025 · Journal of Clinical Pathology · 被引 4)
• Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study (2025 · Cancer · 被引 1)
• Bladder squamous cell carcinoma in situ in the background of condyloma acuminatum in a kidney transplant recipient. (2023 · PubMed · 被引 1)
• Massive Perivillous Fibrin Deposition-A Cause of Recurrent Fetal Demise: A Case Report (2021 · American Journal of Clinical Pathology · 被引 1)
• 84 Multiplex Immunofluorescence and Genomic Profiling of Epstein-Barr Virus Positive Inflammatory Follicular Dendritic Cell Tumor Reveal an Immunosuppressive Tumor Microenvironment (2026 · Laboratory Investigation)
• 1285 WHO5 TP53 allelic state configuration is relevant in patients with TP53 mutated myeloid neoplasms receiving hypomethylating agent (HMA)-based regimens: Interim report of the International TP53 investigators Network (iTIN) (2026 · Laboratory Investigation)